Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Compugen granted U.S. patent for COM701 antibody » 07:10
01/18/22
01/18
07:10
01/18/22
07:10
CGEN

Compugen

$3.88 /

+0.04 (+1.04%)

Compugen has been granted…

Compugen has been granted a new patent by the USPTO covering method of use for COM701, Compugen's potential first-in-class therapeutic antibody targeting PVRIG, or back-up anti-PVRIG antibody, in triple combination with any anti-PD-1 and any anti-TIGIT antibody for the treatment of cancer. The patent augments previously issued patents by expanding and protecting the use of COM701 for treating cancer patients, to include the triplet combination of COM701 with any anti-PD-1 antibody and any anti-TIGIT antibody. The patent is expected to expire no earlier than August 2037 in the U.S.

ShowHide Related Items >><<
CGEN Compugen
$3.88 /

+0.04 (+1.04%)

CGEN Compugen
$3.88 /

+0.04 (+1.04%)

CGEN Compugen
$3.88 /

+0.04 (+1.04%)

Over a month ago
Hot Stocks
Compugen reports results from trial of COM701 » 07:05
12/09/21
12/09
07:05
12/09/21
07:05
CGEN

Compugen

$4.62 /

+0.2 (+4.53%)

Compugen announced the…

Compugen announced the presentation of preliminary translational data from patient biopsies demonstrating immune activation in the tumor microenvironment after treatment with COM701, Compugen's potentially first-in-class anti-PVRIG antibody, as a monotherapy and in combination with nivolumab at the TIGIT Therapies Digital Summit. "These translational data are exciting as they represent the first demonstration of immune activation in the TME of patients who have been treated with COM701 monotherapy or in combination with nivolumab and add to previous data showing immune activation in peripheral blood taken from treated patients," said Eran Ophir, Ph.D., Vice President of Research and Drug Discovery at Compugen. "In addition, we are encouraged by the observed increases in clonal expansion of T cells, immune infiltration and immune activation in an MSS-CRC patient with a confirmed response after COM701 and nivolumab combination therapy given this is an indication that is unlikely to respond to PD-1 blockade. These results are consistent with our earlier findings supporting PVRIG pathway involvement in early differentiation memory T cell priming and activation and provide important evidence of immune modulation at the location critical for efficacy, the tumor site."

ShowHide Related Items >><<
CGEN Compugen
$4.62 /

+0.2 (+4.53%)

CGEN Compugen
$4.62 /

+0.2 (+4.53%)

CGEN Compugen
$4.62 /

+0.2 (+4.53%)

CGEN Compugen
$4.62 /

+0.2 (+4.53%)

Conference/Events
JMP Securities to hold a virtual summit » 04:55
12/07/21
12/07
04:55
12/07/21
04:55
ALLO

Allogene Therapeutics

$17.19 /

-0.45 (-2.55%)

, BCYC

Bicycle Therapeutics

$50.35 /

-2.24 (-4.26%)

, BCAB

BioAtla

$22.46 /

+0.105 (+0.47%)

, BCRX

BioCryst

$11.18 /

-0.275 (-2.40%)

, BPMC

Blueprint Medicines

$95.36 /

+1.105 (+1.17%)

, CLLS

Cellectis

$8.08 /

-0.18 (-2.18%)

, CGEN

Compugen

$4.20 /

+0.03 (+0.72%)

, CTIC

CTI BioPharma

$1.68 /

+0.075 (+4.69%)

, CUE

Cue Biopharma

$10.94 /

-0.45 (-3.95%)

, CVAC

CureVac

$40.76 /

-2.91 (-6.66%)

, DCPH

Deciphera

$8.03 /

+0.03 (+0.38%)

, EFTR

eFfector Therapeutics

$7.44 /

+1.7 (+29.62%)

, GMDA

Gamida Cell

$2.34 /

-0.015 (-0.64%)

, HOOK

Hookipa Pharma

$2.94 /

+ (+0.00%)

, INBX

Inhibrx

$36.50 /

-0.49 (-1.32%)

, IOVA

Iovance Biotherapeutics

$16.93 /

+0.37 (+2.23%)

, KURA

Kura Oncology

$12.41 /

-0.05 (-0.40%)

, MGN

Mines Management

$1.13 /

+ (+0.00%)

, MOR

MorphoSys

$9.07 /

-0.39 (-4.12%)

, NXTC

NextCure

$5.84 /

+0.1 (+1.74%)

, PTGX

Protagonist Therapeutics

$32.77 /

+0.43 (+1.33%)

, PRTA

Prothena

$44.06 /

-2.565 (-5.50%)

, SPPI

Spectrum

$1.37 /

-0.005 (-0.36%)

, SYRS

Syros Pharmaceuticals

$3.96 /

+0.39 (+10.92%)

, VOR

Vor Biopharma

$13.15 /

+0.5 (+3.95%)

Hematology & Oncology…

Hematology & Oncology Virtual Summit to be held on December 6-7.Webcast Link

ShowHide Related Items >><<
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

NXTC NextCure
$5.84 /

+0.1 (+1.74%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

12/03/21 Canaccord
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord
10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
10/12/21 JMP Securities
Allogene Therapeutics price target lowered to $27 from $53 at JMP Securities
10/08/21
Fly Intel: Top five analyst downgrades
BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

10/14/21 JMP Securities
Bicycle Therapeutics price target raised to $85 from $53 at JMP Securities
10/11/21 Canaccord
Bicycle Therapeutics price target raised to $60 from $40 at Canaccord
10/08/21 Oppenheimer
Bicycle Therapeutics price target raised to $65 from $47 at Oppenheimer
10/08/21 B. Riley
Bicycle Therapeutics price target raised to $72 from $56 at B. Riley
BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

10/14/21 BTIG
BioAtla assumed with a Buy at BTIG
06/28/21 Roth Capital
BioAtla initiated with a Buy at Roth Capital
05/04/21 Credit Suisse
BioAtla assumed with an Outperform at Credit Suisse
05/04/21 JPMorgan
BioAtla price target raised to $64 from $45 at JPMorgan
BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

12/01/21 Raymond James
Blueprint Medicines added to Analyst Current Favorites list at Raymond James
11/29/21 Stifel
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics
11/29/21 Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

11/30/21 JMP Securities
Cellectis initiated with an Outperform at JMP Securities
11/08/21 William Blair
Cellectis downgraded to Market Perform at William Blair on slow execution
11/08/21 William Blair
Cellectis downgraded to Market Perform from Outperform at William Blair
10/08/21 Baird
Baird cuts Cellectis to Neutral after partner Allogene's clinical hold
CGEN Compugen
$4.20 /

+0.03 (+0.72%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
CureVac initiated with a Hold at Deutsche Bank
07/01/21 Berenberg
CureVac COVID vaccine data may be enough for EU approval, says Berenberg
06/30/21
CureVac announces COVID vaccine candidate demonstrates 48% efficacy
DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

12/01/21 H.C. Wainwright
Deciphera price target lowered to $15 from $25 at H.C. Wainwright
11/30/21 Piper Sandler
Deciphera price target lowered to $11 from $14 at Piper Sandler
11/08/21 Barclays
Deciphera downgraded to Equal Weight at Barclays after GIST trial miss
11/08/21 Canaccord
Deciphera downgraded to Hold at Canaccord
EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

11/16/21 H.C. Wainwright
Gamida Cell price target lowered to $22 from $27 at H.C. Wainwright
11/16/21 Oppenheimer
Gamida Cell price target lowered to $15 from $17 at Oppenheimer
11/15/21 Piper Sandler
Gamida Cell price target lowered to $13 from $23 at Piper Sandler
11/01/21 Alliance Global Partners
Gamida Cell initiated with a Buy at Alliance Global Partners
HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/12/21 Morgan Stanley
Hookipa Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/21 H.C. Wainwright
Hookipa Pharma price target lowered to $15 from $21 at H.C. Wainwright
11/10/21 JMP Securities
Hookipa Pharma price target lowered to $11 from $25 at JMP Securities
INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
11/02/21 JMP Securities
Inhibrx price target raised to $53 from $46 at JMP Securities
09/21/21 JMP Securities
Inhibrx initiated with an Outperform at JMP Securities
04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

12/06/21 Cowen
Iovance Biotherapeutics assumed with an Outperform at Cowen
11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

11/26/21 Credit Suisse
Kura Oncology price target lowered to $21 from $40 at Credit Suisse
11/24/21 H.C. Wainwright
Kura Oncology price target lowered to $32 from $43 at H.C. Wainwright
05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
MGN Mines Management
$1.13 /

+ (+0.00%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

11/12/21 Morgan Stanley
MorphoSys price target raised to EUR 76 from EUR 75 at Morgan Stanley
09/27/21 Citi
MorphoSys downgraded to Neutral from Buy at Citi
09/13/21 Goldman Sachs
MorphoSys reinstated with a Neutral at Goldman Sachs
09/02/21 Barclays
MorphoSys price target lowered to EUR 47 from EUR 90 at Barclays
NXTC NextCure
$5.84 /

+0.1 (+1.74%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

11/15/21 JMP Securities
Protagonist Therapeutics price target raised to $70 from $60 at JMP Securities
11/04/21 Piper Sandler
Piper 'pleasantly surprised' by Protagonist Therapeutics' ASH abstracts
10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
PRTA Prothena
$44.06 /

-2.565 (-5.50%)

11/19/21 JMP Securities
Prothena initiated with an Outperform at JMP Securities
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
09/27/21 Oppenheimer
Prothena price target raised to $100 from $90 at Oppenheimer
09/20/21 Fox Advisors
Prothena initiated with an Overweight at Fox Advisors
SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

09/27/21 Roth Capital
Veteran Chee coming aboard a positive for Syros, says Roth Capital
09/23/21 Roth Capital
Syros Pharmaceuticals price target raised to $23 from $20 at Roth Capital
05/06/21 Piper Sandler
Syros Pharmaceuticals selloff a buying opportunity, says Piper Sandler
03/05/21 Alliance Global Partners
Syros price target lowered to $14 from $18 at Alliance Global Partners
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

NXTC NextCure
$5.84 /

+0.1 (+1.74%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

  • 13
    Oct
  • 11
    Aug
  • 16
    Jun
  • 01
    Apr
  • 24
    Mar
  • 05
    Feb
  • 28
    Jan
  • 20
    Jan
  • 16
    Dec
  • 16
    Dec
  • 11
    Dec
  • 09
    Dec
  • 09
    Dec
SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

Conference/Events
JMP Securities to hold a virtual summit » 10:28
12/06/21
12/06
10:28
12/06/21
10:28
ALLO

Allogene Therapeutics

$17.54 /

-0.1 (-0.57%)

, BCYC

Bicycle Therapeutics

$51.39 /

-1.2 (-2.28%)

, BCAB

BioAtla

$23.00 /

+0.65 (+2.91%)

, BCRX

BioCryst

$10.98 /

-0.47 (-4.10%)

, BPMC

Blueprint Medicines

$93.08 /

-1.175 (-1.25%)

, CLLS

Cellectis

$8.11 /

-0.15 (-1.82%)

, CGEN

Compugen

$4.17 /

+ (+0.00%)

, CTIC

CTI BioPharma

$1.55 /

-0.05 (-3.13%)

, CUE

Cue Biopharma

$11.08 /

-0.31 (-2.72%)

, CVAC

CureVac

$42.70 /

-0.97 (-2.22%)

, DCPH

Deciphera

$8.00 /

+ (+0.00%)

, EFTR

eFfector Therapeutics

$6.04 /

+0.3 (+5.23%)

, GMDA

Gamida Cell

$2.30 /

-0.055 (-2.34%)

, HOOK

Hookipa Pharma

$2.95 /

+0.01 (+0.34%)

, INBX

Inhibrx

$36.71 /

-0.28 (-0.76%)

, IOVA

Iovance Biotherapeutics

$16.75 /

+0.19 (+1.15%)

, KURA

Kura Oncology

$12.37 /

-0.09 (-0.72%)

, MGN

Mines Management

$1.13 /

+ (+0.00%)

, MOR

MorphoSys

$9.19 /

-0.27 (-2.85%)

, NXTC

NextCure

$5.79 /

+0.05 (+0.87%)

, PTGX

Protagonist Therapeutics

$32.52 /

+0.18 (+0.56%)

, PRTA

Prothena

$45.07 /

-1.555 (-3.34%)

, SPPI

Spectrum

$1.37 /

-0.01 (-0.73%)

, SYRS

Syros Pharmaceuticals

$3.60 /

+0.03 (+0.84%)

, VOR

Vor Biopharma

$12.80 /

+0.15 (+1.19%)

Hematology & Oncology…

Hematology & Oncology Virtual Summit to be held on December 6-7.Webcast Link

ShowHide Related Items >><<
VOR Vor Biopharma
$12.80 /

+0.15 (+1.19%)

SYRS Syros Pharmaceuticals
$3.60 /

+0.03 (+0.84%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

PRTA Prothena
$45.07 /

-1.555 (-3.34%)

NXTC NextCure
$5.79 /

+0.05 (+0.87%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

HOOK Hookipa Pharma
$2.95 /

+0.01 (+0.34%)

GMDA Gamida Cell
$2.30 /

-0.055 (-2.34%)

EFTR eFfector Therapeutics
$6.04 /

+0.3 (+5.23%)

DCPH Deciphera
$8.00 /

+ (+0.00%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CUE Cue Biopharma
$11.08 /

-0.31 (-2.72%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

CLLS Cellectis
$8.11 /

-0.15 (-1.82%)

CGEN Compugen
$4.17 /

+ (+0.00%)

BPMC Blueprint Medicines
$93.08 /

-1.175 (-1.25%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

12/03/21 Canaccord
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord
10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
10/12/21 JMP Securities
Allogene Therapeutics price target lowered to $27 from $53 at JMP Securities
10/08/21
Fly Intel: Top five analyst downgrades
BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

10/14/21 JMP Securities
Bicycle Therapeutics price target raised to $85 from $53 at JMP Securities
10/11/21 Canaccord
Bicycle Therapeutics price target raised to $60 from $40 at Canaccord
10/08/21 Oppenheimer
Bicycle Therapeutics price target raised to $65 from $47 at Oppenheimer
10/08/21 B. Riley
Bicycle Therapeutics price target raised to $72 from $56 at B. Riley
BCAB BioAtla
$23.00 /

+0.65 (+2.91%)

10/14/21 BTIG
BioAtla assumed with a Buy at BTIG
06/28/21 Roth Capital
BioAtla initiated with a Buy at Roth Capital
05/04/21 Credit Suisse
BioAtla assumed with an Outperform at Credit Suisse
05/04/21 JPMorgan
BioAtla price target raised to $64 from $45 at JPMorgan
BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
BPMC Blueprint Medicines
$93.08 /

-1.175 (-1.25%)

12/01/21 Raymond James
Blueprint Medicines added to Analyst Current Favorites list at Raymond James
11/29/21 Stifel
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics
11/29/21 Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
CLLS Cellectis
$8.11 /

-0.15 (-1.82%)

11/30/21 JMP Securities
Cellectis initiated with an Outperform at JMP Securities
11/08/21 William Blair
Cellectis downgraded to Market Perform at William Blair on slow execution
11/08/21 William Blair
Cellectis downgraded to Market Perform from Outperform at William Blair
10/08/21 Baird
Baird cuts Cellectis to Neutral after partner Allogene's clinical hold
CGEN Compugen
$4.17 /

+ (+0.00%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
CUE Cue Biopharma
$11.08 /

-0.31 (-2.72%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
CureVac initiated with a Hold at Deutsche Bank
07/01/21 Berenberg
CureVac COVID vaccine data may be enough for EU approval, says Berenberg
06/30/21
CureVac announces COVID vaccine candidate demonstrates 48% efficacy
DCPH Deciphera
$8.00 /

+ (+0.00%)

12/01/21 H.C. Wainwright
Deciphera price target lowered to $15 from $25 at H.C. Wainwright
11/30/21 Piper Sandler
Deciphera price target lowered to $11 from $14 at Piper Sandler
11/08/21 Barclays
Deciphera downgraded to Equal Weight at Barclays after GIST trial miss
11/08/21 Canaccord
Deciphera downgraded to Hold at Canaccord
EFTR eFfector Therapeutics
$6.04 /

+0.3 (+5.23%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
GMDA Gamida Cell
$2.30 /

-0.055 (-2.34%)

11/16/21 H.C. Wainwright
Gamida Cell price target lowered to $22 from $27 at H.C. Wainwright
11/16/21 Oppenheimer
Gamida Cell price target lowered to $15 from $17 at Oppenheimer
11/15/21 Piper Sandler
Gamida Cell price target lowered to $13 from $23 at Piper Sandler
11/01/21 Alliance Global Partners
Gamida Cell initiated with a Buy at Alliance Global Partners
HOOK Hookipa Pharma
$2.95 /

+0.01 (+0.34%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/12/21 Morgan Stanley
Hookipa Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/21 H.C. Wainwright
Hookipa Pharma price target lowered to $15 from $21 at H.C. Wainwright
11/10/21 JMP Securities
Hookipa Pharma price target lowered to $11 from $25 at JMP Securities
INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
11/02/21 JMP Securities
Inhibrx price target raised to $53 from $46 at JMP Securities
09/21/21 JMP Securities
Inhibrx initiated with an Outperform at JMP Securities
04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

11/26/21 Credit Suisse
Kura Oncology price target lowered to $21 from $40 at Credit Suisse
11/24/21 H.C. Wainwright
Kura Oncology price target lowered to $32 from $43 at H.C. Wainwright
05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
MGN Mines Management
$1.13 /

+ (+0.00%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

11/12/21 Morgan Stanley
MorphoSys price target raised to EUR 76 from EUR 75 at Morgan Stanley
09/27/21 Citi
MorphoSys downgraded to Neutral from Buy at Citi
09/13/21 Goldman Sachs
MorphoSys reinstated with a Neutral at Goldman Sachs
09/02/21 Barclays
MorphoSys price target lowered to EUR 47 from EUR 90 at Barclays
NXTC NextCure
$5.79 /

+0.05 (+0.87%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

11/15/21 JMP Securities
Protagonist Therapeutics price target raised to $70 from $60 at JMP Securities
11/04/21 Piper Sandler
Piper 'pleasantly surprised' by Protagonist Therapeutics' ASH abstracts
10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
PRTA Prothena
$45.07 /

-1.555 (-3.34%)

11/19/21 JMP Securities
Prothena initiated with an Outperform at JMP Securities
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
09/27/21 Oppenheimer
Prothena price target raised to $100 from $90 at Oppenheimer
09/20/21 Fox Advisors
Prothena initiated with an Overweight at Fox Advisors
SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
SYRS Syros Pharmaceuticals
$3.60 /

+0.03 (+0.84%)

09/27/21 Roth Capital
Veteran Chee coming aboard a positive for Syros, says Roth Capital
09/23/21 Roth Capital
Syros Pharmaceuticals price target raised to $23 from $20 at Roth Capital
05/06/21 Piper Sandler
Syros Pharmaceuticals selloff a buying opportunity, says Piper Sandler
03/05/21 Alliance Global Partners
Syros price target lowered to $14 from $18 at Alliance Global Partners
VOR Vor Biopharma
$12.80 /

+0.15 (+1.19%)

12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
VOR Vor Biopharma
$12.80 /

+0.15 (+1.19%)

SYRS Syros Pharmaceuticals
$3.60 /

+0.03 (+0.84%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

PRTA Prothena
$45.07 /

-1.555 (-3.34%)

NXTC NextCure
$5.79 /

+0.05 (+0.87%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

HOOK Hookipa Pharma
$2.95 /

+0.01 (+0.34%)

GMDA Gamida Cell
$2.30 /

-0.055 (-2.34%)

EFTR eFfector Therapeutics
$6.04 /

+0.3 (+5.23%)

DCPH Deciphera
$8.00 /

+ (+0.00%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CUE Cue Biopharma
$11.08 /

-0.31 (-2.72%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

CLLS Cellectis
$8.11 /

-0.15 (-1.82%)

CGEN Compugen
$4.17 /

+ (+0.00%)

BPMC Blueprint Medicines
$93.08 /

-1.175 (-1.25%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

BCAB BioAtla
$23.00 /

+0.65 (+2.91%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

  • 13
    Oct
  • 11
    Aug
  • 16
    Jun
  • 01
    Apr
  • 24
    Mar
  • 05
    Feb
  • 28
    Jan
  • 20
    Jan
  • 16
    Dec
  • 16
    Dec
  • 11
    Dec
  • 09
    Dec
  • 09
    Dec
SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CGEN Compugen
$4.17 /

+ (+0.00%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

PRTA Prothena
$45.07 /

-1.555 (-3.34%)

MOR MorphoSys
$9.19 /

-0.27 (-2.85%)

KURA Kura Oncology
$12.37 /

-0.09 (-0.72%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

DCPH Deciphera
$8.00 /

+ (+0.00%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

CTIC CTI BioPharma
$1.55 /

-0.05 (-3.13%)

CGEN Compugen
$4.17 /

+ (+0.00%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

SPPI Spectrum
$1.37 /

-0.01 (-0.73%)

PTGX Protagonist Therapeutics
$32.52 /

+0.18 (+0.56%)

IOVA Iovance Biotherapeutics
$16.75 /

+0.19 (+1.15%)

INBX Inhibrx
$36.71 /

-0.28 (-0.76%)

CVAC CureVac
$42.70 /

-0.97 (-2.22%)

BCYC Bicycle Therapeutics
$51.39 /

-1.2 (-2.28%)

BCRX BioCryst
$10.98 /

-0.47 (-4.10%)

BCAB BioAtla
$23.00 /

+0.65 (+2.91%)

ALLO Allogene Therapeutics
$17.54 /

-0.1 (-0.57%)

Conference/Events
Compugen participates in a conference call with JMP Securities » 04:55
11/29/21
11/29
04:55
11/29/21
04:55
CGEN

Compugen

$4.54 /

-0.08 (-1.73%)

Conference call with…

Conference call with management will be held on November 29 hosted by JMP Securities.

ShowHide Related Items >><<
CGEN Compugen
$4.54 /

-0.08 (-1.73%)

CGEN Compugen
$4.54 /

-0.08 (-1.73%)

CGEN Compugen
$4.54 /

-0.08 (-1.73%)

CGEN Compugen
$4.54 /

-0.08 (-1.73%)

Conference/Events
Compugen participates in a conference call with JMP Securities » 13:02
11/22/21
11/22
13:02
11/22/21
13:02
CGEN

Compugen

$4.54 /

-0.18 (-3.81%)

Conference call with…

Conference call with management will be held on November 29 hosted by JMP Securities.

ShowHide Related Items >><<
CGEN Compugen
$4.54 /

-0.18 (-3.81%)

CGEN Compugen
$4.54 /

-0.18 (-3.81%)

CGEN Compugen
$4.54 /

-0.18 (-3.81%)

CGEN Compugen
$4.54 /

-0.18 (-3.81%)

Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting » 04:55
11/14/21
11/14
04:55
11/14/21
04:55
CRSP

Crispr Therapeutics

$89.14 /

+1.14 (+1.30%)

, REGN

Regeneron

$631.22 /

+4.71 (+0.75%)

, ACHL

Achilles Therapeutics

$6.17 /

-0.29 (-4.49%)

, ALEX

Alexander & Baldwin

$24.52 /

-0.51 (-2.04%)

, ALXO

ALX Oncology

$45.94 /

+2.07 (+4.72%)

, ARAV

Aravive

$4.03 /

+0.24 (+6.33%)

, CGEN

Compugen

$5.87 /

-1.29 (-18.02%)

, CRVS

Corvus Pharmaceuticals

$4.18 /

-0.285 (-6.39%)

, FATE

Fate Therapeutics

$55.73 /

-0.73 (-1.29%)

, GILD

Gilead

$67.48 /

+0.07 (+0.10%)

, GRCL

Gracell

$10.87 /

-0.36 (-3.21%)

, HARP

Harpoon Therapeutics

$7.66 /

-0.09 (-1.16%)

, IMAB

I-Mab

$60.16 /

-0.85 (-1.39%)

, IMMP

Immutep

$4.27 /

+0.27 (+6.75%)

, IMV

IMV Inc.

$1.55 /

+0.01 (+0.65%)

, IOVA

Iovance Biotherapeutics

$21.16 /

-2.345 (-9.98%)

, LIFE

aTyr Pharma

$8.74 /

+0.08 (+0.92%)

, MRK

Merck

$84.02 /

+ (+0.00%)

, MRNA

Moderna

$231.26 /

+5.3 (+2.35%)

, SNSE

Sensei Biotherapeutics

$9.61 /

+1.01 (+11.74%)

, SGEN

Seagen

$178.94 /

+1.395 (+0.79%)

, PSTX

Poseida Therapeutics

$7.31 /

+0.16 (+2.24%)

, ONCS

OncoSec

$1.75 /

+0.03 (+1.74%)

, ONCR

Oncorus

$6.01 /

-5.195 (-46.38%)

, NXTC

NextCure

$6.42 /

-0.18 (-2.73%)

, NRIX

Nurix Therapeutics

$34.10 /

+1.03 (+3.11%)

, NLTX

Neoleukin Therapeutics

$6.34 /

-0.05 (-0.78%)

, STTK

Shattuck Labs

$12.52 /

-0.63 (-4.79%)

, TPST

Tempest Therapeutics

$11.40 /

-0.45 (-3.80%)

, ANCR

Ancor Communications

/

+

SITC 2021 to be held in…

SITC 2021 to be held in Washington, D.C. on November 10-14. Webcast Link

ShowHide Related Items >><<
TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

SGEN Seagen
$178.94 /

+1.395 (+0.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

PSTX Poseida Therapeutics
$7.31 /

+0.16 (+2.24%)

ONCS OncoSec
$1.75 /

+0.03 (+1.74%)

ONCR Oncorus
$6.01 /

-5.195 (-46.38%)

NXTC NextCure
$6.42 /

-0.18 (-2.73%)

NRIX Nurix Therapeutics
$34.10 /

+1.03 (+3.11%)

NLTX Neoleukin Therapeutics
$6.34 /

-0.05 (-0.78%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

IMV IMV Inc.
$1.55 /

+0.01 (+0.65%)

IMMP Immutep
$4.27 /

+0.27 (+6.75%)

IMAB I-Mab
$60.16 /

-0.85 (-1.39%)

HARP Harpoon Therapeutics
$7.66 /

-0.09 (-1.16%)

GRCL Gracell
$10.87 /

-0.36 (-3.21%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

ARAV Aravive
$4.03 /

+0.24 (+6.33%)

ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

ALEX Alexander & Baldwin
$24.52 /

-0.51 (-2.04%)

ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
10/19/21 SVB Leerink
Crispr Therapeutics initiated with an Outperform at SVB Leerink
REGN Regeneron
$631.22 /

+4.71 (+0.75%)

11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
11/05/21
Fly Intel: Top five analyst downgrades
11/05/21 Benchmark
Regeneron downgraded to Hold from Buy at Benchmark
ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

11/12/21 Piper Sandler
Achilles provides clinical update for ATL001 trials, says Piper Sandler
08/10/21 Piper Sandler
Achilles Therapeutics price target lowered to $23 from $25 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
ALEX Alexander & Baldwin
$24.52 /

-0.51 (-2.04%)

07/30/21 Piper Sandler
Alexander & Baldwin upgraded to Overweight from Neutral at Piper Sandler
12/23/20 Piper Sandler
Alexander & Baldwin price target raised to $17 from $13 at Piper Sandler
ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

11/09/21 Piper Sandler
ALX Oncology price target lowered to $85 from $97 at Piper Sandler
11/09/21 H.C. Wainwright
H.C. Wainwright says ALX Oncology selloff on ASPEN-01 data an entry opportunity
11/04/21 Piper Sandler
ALX Oncology selloff after ASH abstract 'wholly misplaced,' says Piper Sandler
09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
ARAV Aravive
$4.03 /

+0.24 (+6.33%)

11/09/21 Piper Sandler
Aravive data show preliminary efficacy in ccRCC, says Piper Sandler
08/06/21 Piper Sandler
Aravive price target lowered to $18 from $20 at Piper Sandler
04/27/21 Piper Sandler
Aravive doses first patient in Phase III AVB-500 trial, says Piper Sandler
03/08/21
Fly Intel: Top five analyst initiations
CGEN Compugen
$5.87 /

-1.29 (-18.02%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
08/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target lowered to $5 from $10 at Cantor Fitzgerald
08/03/21 Mizuho
Corvus Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
07/16/21 H.C. Wainwright
Corvus Pharmaceuticals price target lowered to $6 from $9.50 at H.C. Wainwright
FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

11/08/21 Citi
Fate Therapeutics upgraded to Buy at Citi ahead of SITC and ASH presentations
11/08/21 Citi
Fate Therapeutics upgraded to Buy from Neutral at Citi
11/05/21 Roth Capital
Fate Therapeutics price target lowered to $60 from $90 at Roth Capital
08/26/21
Fly Intel: Top five analyst initiations
GILD Gilead
$67.48 /

+0.07 (+0.10%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/09/21 Barclays
Arcus Biosciences price target raised to $48 from $45 at Barclays
11/09/21 Mizuho
Arcus Biosciences price target raised to $51 from $43 at Mizuho
10/19/21 Cowen
Gilead assumed with an Outperform at Cowen
GRCL Gracell
$10.87 /

-0.36 (-3.21%)

06/14/21 Piper Sandler
Gracell plans to expand GC012F's clinical profile, says Piper Sandler
06/07/21 Citi
Gracell valuation provides attractive entry point, says Citi
06/04/21 Piper Sandler
Piper sees 'clear line of sight for value creation' at Gracell after ASCO
04/30/21 Piper Sandler
Gracell transferred with Overweight rating at Piper Sandler
HARP Harpoon Therapeutics
$7.66 /

-0.09 (-1.16%)

10/27/21 Roth Capital
Harpoon Therapeutics appoints new CEO, Roth Capital expects 'smooth transition'
09/27/21 Citi
Harpoon Therapeutics upgraded to Buy from Neutral at Citi
08/06/21 Piper Sandler
Harpoon Therapeutics price target lowered to $30 from $35 at Piper Sandler
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
IMAB I-Mab
$60.16 /

-0.85 (-1.39%)

09/03/21 Cantor Fitzgerald
Cantor Fitzgerald positive on I-Mab following 'solid' first half
09/01/21 H.C. Wainwright
I-Mab price target raised to $95 from $75 at H.C. Wainwright
07/26/21 Cantor Fitzgerald
I-Mab's overdone weakness a buying opportunity, says Cantor Fitzgerald
07/13/21 Cantor Fitzgerald
I-Mab price target raised to $95 from $90 at Cantor Fitzgerald
IMMP Immutep
$4.27 /

+0.27 (+6.75%)

08/03/21 Ladenburg
Ladenburg starts Immutep with Buy into 'value-driving' events
08/03/21 Ladenburg
Immutep initiated with a Buy at Ladenburg
07/16/21 Maxim
Immutep assumed with a Buy at Maxim
06/10/21 Alliance Global Partners
Immutep price target raised to $9 from $6 at Alliance Global Partners
IMV IMV Inc.
$1.55 /

+0.01 (+0.65%)

09/22/21 Cantor Fitzgerald
IMV Inc initiated with an Overweight at Cantor Fitzgerald
09/22/21 Cantor Fitzgerald
IMV Inc. initiated with an Overweight at Cantor Fitzgerald
07/23/21 Wells Fargo
IMV Inc. resumed with an Overweight at Wells Fargo
05/13/21 National Bank
IMV Inc. price target lowered to C$4.25 from C$5.25 at National Bank
IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 H.C. Wainwright
Iovance lung cancer data should improve with time, says H.C. Wainwright
LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

11/11/21 Roth Capital
aTyr Pharma 2022 catalysts 'should be on your radar,' says Roth Capital
10/12/21 RBC Capital
aTyr Pharma initiated with an Outperform at RBC Capital
09/21/21 Piper Sandler
aTyr Pharma initiated with an Overweight at Piper Sandler
09/14/21 Oppenheimer
aTyr Pharma price target raised to $20 from $14 at Oppenheimer
MRK Merck
$84.02 /

+ (+0.00%)

11/05/21 Cowen
Pfizer 'looks to have edge' in COVID oral antivirals, says Cowen
11/01/21 Argus
Merck upgraded to Buy from Hold at Argus
11/01/21 Argus
Merck upgraded to Buy from Hold at Argus
MRNA Moderna
$231.26 /

+5.3 (+2.35%)

11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
11/08/21 Wolfe Research
Moderna initiated with an Outperform at Wolfe Research
11/05/21 Jefferies
Moderna price target lowered to $325 from $375 at Jefferies
11/05/21 Evercore ISI
Denali Therapeutics price target raised to $111 from $70 at Evercore ISI
SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
SGEN Seagen
$178.94 /

+1.395 (+0.79%)

11/08/21 Wolfe Research
Seagen initiated with a Peer Perform at Wolfe Research
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
PSTX Poseida Therapeutics
$7.31 /

+0.16 (+2.24%)

10/12/21 Piper Sandler
Poseida Therapeutics price target raised to $19 from $17 at Piper Sandler
08/31/21 Piper Sandler
Poseida selloff a buying opportunity, says Piper Sandler
06/30/21 Piper Sandler
Poseida Therapeutics being overlooked after Intellia data, says Piper Sandler
06/23/21 Piper Sandler
Piper says 'time to take a fresh look' at Poseida after CEO meeting
ONCS OncoSec
$1.75 /

+0.03 (+1.74%)

10/14/21 BTIG
OncoSec assumed with a Buy at BTIG
04/15/21 Alliance Global Partners
OncoSec price target raised to $11 from $6.50 at Alliance Global Partners
03/25/21 Maxim
OncoSec price target raised to $12 from $8 at Maxim
ONCR Oncorus
$6.01 /

-5.195 (-46.38%)

11/12/21 Piper Sandler
Piper would be 'aggressive buyers' of Oncorus after '177 data 'as good as hoped'
06/22/21 Piper Sandler
Oncorus investor day 'incrementally positive,' says Piper Sandler
04/19/21 Piper Sandler
Oncorus selloff has nothing to do with fundamentals, says Piper Sandler
03/16/21
Fly Intel: Top five analyst initiations
NXTC NextCure
$6.42 /

-0.18 (-2.73%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
NRIX Nurix Therapeutics
$34.10 /

+1.03 (+3.11%)

10/28/21 Baird
Nurix Therapeutics price target raised to $49 from $46 at Baird
10/27/21 SVB Leerink
Nurix Therapeutics price target raised to $64 from $50 at SVB Leerink
10/27/21 Piper Sandler
Nurix Phase I data 'incredibly encouraging,' says Piper Sandler
10/14/21 SVB Leerink
Nurix Therapeutics initiated with an Outperform at SVB Leerink
NLTX Neoleukin Therapeutics
$6.34 /

-0.05 (-0.78%)

08/06/21
Fly Intel: Top five analyst initiations
08/06/21 Piper Sandler
Neoleukin Therapeutics assumed with an Overweight at Piper Sandler
01/08/21 Piper Sandler
Piper stays Overweight on Neoleukin after hold, sees 'laser-focused' response
01/05/21 Stifel
Neoleukin Therapeutics initiated with a Buy at Stifel
STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

04/14/21 Berenberg
Shattuck Labs initiated with a Buy at Berenberg
01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

10/21/21 William Blair
William Blair starts Tempest Therapeutics with buy on oncology assets
10/21/21 William Blair
Tempest Therapeutics initiated with an Outperform at William Blair
07/13/21
Fly Intel: Top five analyst initiations
07/13/21 H.C. Wainwright
Tempest Therapeutics initiated with a Buy at H.C. Wainwright
ANCR Ancor Communications
/

+

TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

SGEN Seagen
$178.94 /

+1.395 (+0.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

PSTX Poseida Therapeutics
$7.31 /

+0.16 (+2.24%)

ONCR Oncorus
$6.01 /

-5.195 (-46.38%)

NXTC NextCure
$6.42 /

-0.18 (-2.73%)

NRIX Nurix Therapeutics
$34.10 /

+1.03 (+3.11%)

NLTX Neoleukin Therapeutics
$6.34 /

-0.05 (-0.78%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

HARP Harpoon Therapeutics
$7.66 /

-0.09 (-1.16%)

GRCL Gracell
$10.87 /

-0.36 (-3.21%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

ARAV Aravive
$4.03 /

+0.24 (+6.33%)

ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

ALEX Alexander & Baldwin
$24.52 /

-0.51 (-2.04%)

ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

  • 16
    Sep
  • 15
    Jul
  • 31
    Mar
  • 05
    Mar
  • 12
    Feb
  • 12
    Feb
  • 09
    Feb
  • 04
    Feb
  • 21
    Jan
  • 13
    Jan
  • 13
    Jan
  • 07
    Jan
  • 06
    Jan
  • 08
    Jan
  • 10
    Dec
REGN Regeneron
$631.22 /

+4.71 (+0.75%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IMAB I-Mab
$60.16 /

-0.85 (-1.39%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

SGEN Seagen
$178.94 /

+1.395 (+0.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

ONCS OncoSec
$1.75 /

+0.03 (+1.74%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

IMMP Immutep
$4.27 /

+0.27 (+6.75%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

IMMP Immutep
$4.27 /

+0.27 (+6.75%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting » 04:55
11/13/21
11/13
04:55
11/13/21
04:55
CRSP

Crispr Therapeutics

$89.14 /

+1.14 (+1.30%)

, REGN

Regeneron

$631.22 /

+4.71 (+0.75%)

, ACHL

Achilles Therapeutics

$6.17 /

-0.29 (-4.49%)

, ALEX

Alexander & Baldwin

$24.52 /

-0.51 (-2.04%)

, ALXO

ALX Oncology

$45.94 /

+2.07 (+4.72%)

, ARAV

Aravive

$4.03 /

+0.24 (+6.33%)

, CGEN

Compugen

$5.87 /

-1.29 (-18.02%)

, CRVS

Corvus Pharmaceuticals

$4.18 /

-0.285 (-6.39%)

, FATE

Fate Therapeutics

$55.73 /

-0.73 (-1.29%)

, GILD

Gilead

$67.48 /

+0.07 (+0.10%)

, GRCL

Gracell

$10.87 /

-0.36 (-3.21%)

, HARP

Harpoon Therapeutics

$7.66 /

-0.09 (-1.16%)

, IMAB

I-Mab

$60.16 /

-0.85 (-1.39%)

, IMMP

Immutep

$4.27 /

+0.27 (+6.75%)

, IMV

IMV Inc.

$1.55 /

+0.01 (+0.65%)

, IOVA

Iovance Biotherapeutics

$21.16 /

-2.345 (-9.98%)

, LIFE

aTyr Pharma

$8.74 /

+0.08 (+0.92%)

, MRK

Merck

$84.02 /

+ (+0.00%)

, MRNA

Moderna

$231.26 /

+5.3 (+2.35%)

, SNSE

Sensei Biotherapeutics

$9.61 /

+1.01 (+11.74%)

, SGEN

Seagen

$178.94 /

+1.395 (+0.79%)

, PSTX

Poseida Therapeutics

$7.31 /

+0.16 (+2.24%)

, ONCS

OncoSec

$1.75 /

+0.03 (+1.74%)

, ONCR

Oncorus

$6.01 /

-5.195 (-46.38%)

, NXTC

NextCure

$6.42 /

-0.18 (-2.73%)

, NRIX

Nurix Therapeutics

$34.10 /

+1.03 (+3.11%)

, NLTX

Neoleukin Therapeutics

$6.34 /

-0.05 (-0.78%)

, STTK

Shattuck Labs

$12.52 /

-0.63 (-4.79%)

, TPST

Tempest Therapeutics

$11.40 /

-0.45 (-3.80%)

, ANCR

Ancor Communications

/

+

SITC 2021 to be held in…

SITC 2021 to be held in Washington, D.C. on November 10-14. Webcast Link

ShowHide Related Items >><<
TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

SGEN Seagen
$178.94 /

+1.395 (+0.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

PSTX Poseida Therapeutics
$7.31 /

+0.16 (+2.24%)

ONCS OncoSec
$1.75 /

+0.03 (+1.74%)

ONCR Oncorus
$6.01 /

-5.195 (-46.38%)

NXTC NextCure
$6.42 /

-0.18 (-2.73%)

NRIX Nurix Therapeutics
$34.10 /

+1.03 (+3.11%)

NLTX Neoleukin Therapeutics
$6.34 /

-0.05 (-0.78%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

IMV IMV Inc.
$1.55 /

+0.01 (+0.65%)

IMMP Immutep
$4.27 /

+0.27 (+6.75%)

IMAB I-Mab
$60.16 /

-0.85 (-1.39%)

HARP Harpoon Therapeutics
$7.66 /

-0.09 (-1.16%)

GRCL Gracell
$10.87 /

-0.36 (-3.21%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

ARAV Aravive
$4.03 /

+0.24 (+6.33%)

ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

ALEX Alexander & Baldwin
$24.52 /

-0.51 (-2.04%)

ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
10/19/21 SVB Leerink
Crispr Therapeutics initiated with an Outperform at SVB Leerink
REGN Regeneron
$631.22 /

+4.71 (+0.75%)

11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
11/05/21
Fly Intel: Top five analyst downgrades
11/05/21 Benchmark
Regeneron downgraded to Hold from Buy at Benchmark
ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

11/12/21 Piper Sandler
Achilles provides clinical update for ATL001 trials, says Piper Sandler
08/10/21 Piper Sandler
Achilles Therapeutics price target lowered to $23 from $25 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
ALEX Alexander & Baldwin
$24.52 /

-0.51 (-2.04%)

07/30/21 Piper Sandler
Alexander & Baldwin upgraded to Overweight from Neutral at Piper Sandler
12/23/20 Piper Sandler
Alexander & Baldwin price target raised to $17 from $13 at Piper Sandler
ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

11/09/21 Piper Sandler
ALX Oncology price target lowered to $85 from $97 at Piper Sandler
11/09/21 H.C. Wainwright
H.C. Wainwright says ALX Oncology selloff on ASPEN-01 data an entry opportunity
11/04/21 Piper Sandler
ALX Oncology selloff after ASH abstract 'wholly misplaced,' says Piper Sandler
09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
ARAV Aravive
$4.03 /

+0.24 (+6.33%)

11/09/21 Piper Sandler
Aravive data show preliminary efficacy in ccRCC, says Piper Sandler
08/06/21 Piper Sandler
Aravive price target lowered to $18 from $20 at Piper Sandler
04/27/21 Piper Sandler
Aravive doses first patient in Phase III AVB-500 trial, says Piper Sandler
03/08/21
Fly Intel: Top five analyst initiations
CGEN Compugen
$5.87 /

-1.29 (-18.02%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
08/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target lowered to $5 from $10 at Cantor Fitzgerald
08/03/21 Mizuho
Corvus Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
07/16/21 H.C. Wainwright
Corvus Pharmaceuticals price target lowered to $6 from $9.50 at H.C. Wainwright
FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

11/08/21 Citi
Fate Therapeutics upgraded to Buy at Citi ahead of SITC and ASH presentations
11/08/21 Citi
Fate Therapeutics upgraded to Buy from Neutral at Citi
11/05/21 Roth Capital
Fate Therapeutics price target lowered to $60 from $90 at Roth Capital
08/26/21
Fly Intel: Top five analyst initiations
GILD Gilead
$67.48 /

+0.07 (+0.10%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/09/21 Barclays
Arcus Biosciences price target raised to $48 from $45 at Barclays
11/09/21 Mizuho
Arcus Biosciences price target raised to $51 from $43 at Mizuho
10/19/21 Cowen
Gilead assumed with an Outperform at Cowen
GRCL Gracell
$10.87 /

-0.36 (-3.21%)

06/14/21 Piper Sandler
Gracell plans to expand GC012F's clinical profile, says Piper Sandler
06/07/21 Citi
Gracell valuation provides attractive entry point, says Citi
06/04/21 Piper Sandler
Piper sees 'clear line of sight for value creation' at Gracell after ASCO
04/30/21 Piper Sandler
Gracell transferred with Overweight rating at Piper Sandler
HARP Harpoon Therapeutics
$7.66 /

-0.09 (-1.16%)

10/27/21 Roth Capital
Harpoon Therapeutics appoints new CEO, Roth Capital expects 'smooth transition'
09/27/21 Citi
Harpoon Therapeutics upgraded to Buy from Neutral at Citi
08/06/21 Piper Sandler
Harpoon Therapeutics price target lowered to $30 from $35 at Piper Sandler
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
IMAB I-Mab
$60.16 /

-0.85 (-1.39%)

09/03/21 Cantor Fitzgerald
Cantor Fitzgerald positive on I-Mab following 'solid' first half
09/01/21 H.C. Wainwright
I-Mab price target raised to $95 from $75 at H.C. Wainwright
07/26/21 Cantor Fitzgerald
I-Mab's overdone weakness a buying opportunity, says Cantor Fitzgerald
07/13/21 Cantor Fitzgerald
I-Mab price target raised to $95 from $90 at Cantor Fitzgerald
IMMP Immutep
$4.27 /

+0.27 (+6.75%)

08/03/21 Ladenburg
Ladenburg starts Immutep with Buy into 'value-driving' events
08/03/21 Ladenburg
Immutep initiated with a Buy at Ladenburg
07/16/21 Maxim
Immutep assumed with a Buy at Maxim
06/10/21 Alliance Global Partners
Immutep price target raised to $9 from $6 at Alliance Global Partners
IMV IMV Inc.
$1.55 /

+0.01 (+0.65%)

09/22/21 Cantor Fitzgerald
IMV Inc initiated with an Overweight at Cantor Fitzgerald
09/22/21 Cantor Fitzgerald
IMV Inc. initiated with an Overweight at Cantor Fitzgerald
07/23/21 Wells Fargo
IMV Inc. resumed with an Overweight at Wells Fargo
05/13/21 National Bank
IMV Inc. price target lowered to C$4.25 from C$5.25 at National Bank
IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 H.C. Wainwright
Iovance lung cancer data should improve with time, says H.C. Wainwright
LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

11/11/21 Roth Capital
aTyr Pharma 2022 catalysts 'should be on your radar,' says Roth Capital
10/12/21 RBC Capital
aTyr Pharma initiated with an Outperform at RBC Capital
09/21/21 Piper Sandler
aTyr Pharma initiated with an Overweight at Piper Sandler
09/14/21 Oppenheimer
aTyr Pharma price target raised to $20 from $14 at Oppenheimer
MRK Merck
$84.02 /

+ (+0.00%)

11/05/21 Cowen
Pfizer 'looks to have edge' in COVID oral antivirals, says Cowen
11/01/21 Argus
Merck upgraded to Buy from Hold at Argus
11/01/21 Argus
Merck upgraded to Buy from Hold at Argus
MRNA Moderna
$231.26 /

+5.3 (+2.35%)

11/12/21 Piper Sandler
Piper keeps $348 target on Moderna after solid tumor data
11/08/21 Wolfe Research
Moderna initiated with an Outperform at Wolfe Research
11/05/21 Jefferies
Moderna price target lowered to $325 from $375 at Jefferies
11/05/21 Evercore ISI
Denali Therapeutics price target raised to $111 from $70 at Evercore ISI
SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
SGEN Seagen
$178.94 /

+1.395 (+0.79%)

11/08/21 Wolfe Research
Seagen initiated with a Peer Perform at Wolfe Research
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
PSTX Poseida Therapeutics
$7.31 /

+0.16 (+2.24%)

10/12/21 Piper Sandler
Poseida Therapeutics price target raised to $19 from $17 at Piper Sandler
08/31/21 Piper Sandler
Poseida selloff a buying opportunity, says Piper Sandler
06/30/21 Piper Sandler
Poseida Therapeutics being overlooked after Intellia data, says Piper Sandler
06/23/21 Piper Sandler
Piper says 'time to take a fresh look' at Poseida after CEO meeting
ONCS OncoSec
$1.75 /

+0.03 (+1.74%)

10/14/21 BTIG
OncoSec assumed with a Buy at BTIG
04/15/21 Alliance Global Partners
OncoSec price target raised to $11 from $6.50 at Alliance Global Partners
03/25/21 Maxim
OncoSec price target raised to $12 from $8 at Maxim
ONCR Oncorus
$6.01 /

-5.195 (-46.38%)

11/12/21 Piper Sandler
Piper would be 'aggressive buyers' of Oncorus after '177 data 'as good as hoped'
06/22/21 Piper Sandler
Oncorus investor day 'incrementally positive,' says Piper Sandler
04/19/21 Piper Sandler
Oncorus selloff has nothing to do with fundamentals, says Piper Sandler
03/16/21
Fly Intel: Top five analyst initiations
NXTC NextCure
$6.42 /

-0.18 (-2.73%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
NRIX Nurix Therapeutics
$34.10 /

+1.03 (+3.11%)

10/28/21 Baird
Nurix Therapeutics price target raised to $49 from $46 at Baird
10/27/21 SVB Leerink
Nurix Therapeutics price target raised to $64 from $50 at SVB Leerink
10/27/21 Piper Sandler
Nurix Phase I data 'incredibly encouraging,' says Piper Sandler
10/14/21 SVB Leerink
Nurix Therapeutics initiated with an Outperform at SVB Leerink
NLTX Neoleukin Therapeutics
$6.34 /

-0.05 (-0.78%)

08/06/21
Fly Intel: Top five analyst initiations
08/06/21 Piper Sandler
Neoleukin Therapeutics assumed with an Overweight at Piper Sandler
01/08/21 Piper Sandler
Piper stays Overweight on Neoleukin after hold, sees 'laser-focused' response
01/05/21 Stifel
Neoleukin Therapeutics initiated with a Buy at Stifel
STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

04/14/21 Berenberg
Shattuck Labs initiated with a Buy at Berenberg
01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

10/21/21 William Blair
William Blair starts Tempest Therapeutics with buy on oncology assets
10/21/21 William Blair
Tempest Therapeutics initiated with an Outperform at William Blair
07/13/21
Fly Intel: Top five analyst initiations
07/13/21 H.C. Wainwright
Tempest Therapeutics initiated with a Buy at H.C. Wainwright
ANCR Ancor Communications
/

+

TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

SGEN Seagen
$178.94 /

+1.395 (+0.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

PSTX Poseida Therapeutics
$7.31 /

+0.16 (+2.24%)

ONCR Oncorus
$6.01 /

-5.195 (-46.38%)

NXTC NextCure
$6.42 /

-0.18 (-2.73%)

NRIX Nurix Therapeutics
$34.10 /

+1.03 (+3.11%)

NLTX Neoleukin Therapeutics
$6.34 /

-0.05 (-0.78%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

HARP Harpoon Therapeutics
$7.66 /

-0.09 (-1.16%)

GRCL Gracell
$10.87 /

-0.36 (-3.21%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

ARAV Aravive
$4.03 /

+0.24 (+6.33%)

ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

ALEX Alexander & Baldwin
$24.52 /

-0.51 (-2.04%)

ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

  • 16
    Sep
  • 15
    Jul
  • 31
    Mar
  • 05
    Mar
  • 12
    Feb
  • 12
    Feb
  • 09
    Feb
  • 04
    Feb
  • 21
    Jan
  • 13
    Jan
  • 13
    Jan
  • 07
    Jan
  • 06
    Jan
  • 08
    Jan
  • 10
    Dec
REGN Regeneron
$631.22 /

+4.71 (+0.75%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IMAB I-Mab
$60.16 /

-0.85 (-1.39%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

SNSE Sensei Biotherapeutics
$9.61 /

+1.01 (+11.74%)

SGEN Seagen
$178.94 /

+1.395 (+0.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

ONCS OncoSec
$1.75 /

+0.03 (+1.74%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

IMMP Immutep
$4.27 /

+0.27 (+6.75%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

FATE Fate Therapeutics
$55.73 /

-0.73 (-1.29%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

ALXO ALX Oncology
$45.94 /

+2.07 (+4.72%)

ACHL Achilles Therapeutics
$6.17 /

-0.29 (-4.49%)

TPST Tempest Therapeutics
$11.40 /

-0.45 (-3.80%)

STTK Shattuck Labs
$12.52 /

-0.63 (-4.79%)

REGN Regeneron
$631.22 /

+4.71 (+0.75%)

MRNA Moderna
$231.26 /

+5.3 (+2.35%)

MRK Merck
$84.02 /

+ (+0.00%)

LIFE aTyr Pharma
$8.74 /

+0.08 (+0.92%)

IOVA Iovance Biotherapeutics
$21.16 /

-2.345 (-9.98%)

IMMP Immutep
$4.27 /

+0.27 (+6.75%)

GILD Gilead
$67.48 /

+0.07 (+0.10%)

CRVS Corvus Pharmaceuticals
$4.18 /

-0.285 (-6.39%)

CRSP Crispr Therapeutics
$89.14 /

+1.14 (+1.30%)

Conference/Events
Compugen management to meet with Truist » 04:55
11/13/21
11/13
04:55
11/13/21
04:55
CGEN

Compugen

$5.87 /

-1.29 (-18.02%)

Group Breakfast Meeting…

Group Breakfast Meeting with President Cohen-Dayag and CFO Krashin to be held in Washington, D.C. on November 13 hosted by Truist.

ShowHide Related Items >><<
CGEN Compugen
$5.87 /

-1.29 (-18.02%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

CGEN Compugen
$5.87 /

-1.29 (-18.02%)

On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:06
11/12/21
11/12
16:06
11/12/21
16:06
JNJ

Johnson & Johnson

$164.97 /

+1.9 (+1.17%)

, BKNG

Booking Holdings

$2,453.11 /

-23.96 (-0.97%)

, WRBY

Warby Parker

$58.38 /

+4.905 (+9.17%)

, RIDE

Lordstown Motors

$5.67 /

-1.235 (-17.90%)

, JAMF

Jamf Holding

$32.49 /

-8.77 (-21.26%)

, NVDA

Nvidia

$303.98 /

+0.14 (+0.05%)

, PENN

Penn National

$58.32 /

+0.12 (+0.21%)

, CZR

Caesars

$106.10 /

+4.155 (+4.08%)

, HPE

HP Enterprise

$14.66 /

-1.28 (-8.03%)

, LH

LabCorp

$297.46 /

+10.57 (+3.68%)

, SYNH

Syneos Health

$94.00 /

-8.59 (-8.37%)

, GE

General Electric

$107.53 /

+0.555 (+0.52%)

, RIVN

Rivian Automotive

$129.36 /

+6.52 (+5.31%)

, CONE

CyrusOne

$85.23 /

+2.51 (+3.03%)

, SRNE

Sorrento Therapeutics

$6.42 /

+0.045 (+0.71%)

, HYZN

Hyzon Motors

$7.17 /

+0.875 (+13.90%)

, NGD

New Gold

$1.76 /

+0.145 (+9.01%)

, PAGS

PagSeguro Digital

$35.40 /

+1.38 (+4.06%)

, CGEN

Compugen

$5.84 /

-1.32 (-18.44%)

, HEPS

Hepsiburada

$3.56 /

-2.06 (-36.65%)

, FB

Facebook; also tag MVRS

$340.00 /

+12.27 (+3.74%)

, CPNG

Coupang

$26.60 /

-2.575 (-8.83%)

, MAPS

WM Technology

$9.50 /

-2.12 (-18.24%)

, AZN

AstraZeneca

$58.87 /

-4.03 (-6.41%)

, BKKT

Bakkt

$24.43 /

-1.75 (-6.68%)

, BLNK

Blink Charging

$39.98 /

+4.42 (+12.43%)

, SMAR

Smartsheet

$72.69 /

+4.18 (+6.10%)

, FLUX

Flux Power

$6.14 /

+0.03 (+0.49%)

, SVRA

Savara

$1.14 /

-0.02 (-1.72%)

, LAZR

Luminar

$19.59 /

-0.4 (-2.00%)

, AMD

AMD

$147.96 /

+2 (+1.37%)

, XLNX

Xilinx

$213.52 /

+4.69 (+2.25%)

Get caught up quickly on…

ShowHide Related Items >><<
XLNX Xilinx
$213.52 /

+4.69 (+2.25%)

WRBY Warby Parker
$58.38 /

+4.905 (+9.17%)

SYNH Syneos Health
$94.00 /

-8.59 (-8.37%)

SVRA Savara
$1.14 /

-0.02 (-1.72%)

SRNE Sorrento Therapeutics
$6.42 /

+0.045 (+0.71%)

SMAR Smartsheet
$72.69 /

+4.18 (+6.10%)

RIVN Rivian Automotive
$129.36 /

+6.52 (+5.31%)

RIDE Lordstown Motors
$5.67 /

-1.235 (-17.90%)

PENN Penn National
$58.32 /

+0.12 (+0.21%)

PAGS PagSeguro Digital
$35.40 /

+1.38 (+4.06%)

NVDA Nvidia
$303.98 /

+0.14 (+0.05%)

NGD New Gold
$1.76 /

+0.145 (+9.01%)

MAPS WM Technology
$9.50 /

-2.12 (-18.24%)

LH LabCorp
$297.46 /

+10.57 (+3.68%)

LAZR Luminar
$19.59 /

-0.4 (-2.00%)

JNJ Johnson & Johnson
$164.97 /

+1.9 (+1.17%)

JAMF Jamf Holding
$32.49 /

-8.77 (-21.26%)

HYZN Hyzon Motors
$7.17 /

+0.875 (+13.90%)

HPE HP Enterprise
$14.66 /

-1.28 (-8.03%)

HEPS Hepsiburada
$3.56 /

-2.06 (-36.65%)

GE General Electric
$107.53 /

+0.555 (+0.52%)

FLUX Flux Power
$6.14 /

+0.03 (+0.49%)

FB Facebook; also tag MVRS
$340.00 /

+12.27 (+3.74%)

CZR Caesars
$106.10 /

+4.155 (+4.08%)

CPNG Coupang
$26.60 /

-2.575 (-8.83%)

CONE CyrusOne
$85.23 /

+2.51 (+3.03%)

CGEN Compugen
$5.84 /

-1.32 (-18.44%)

BLNK Blink Charging
$39.98 /

+4.42 (+12.43%)

BKNG Booking Holdings
$2,453.11 /

-23.96 (-0.97%)

BKKT Bakkt
$24.43 /

-1.75 (-6.68%)

AZN AstraZeneca
$58.87 /

-4.03 (-6.41%)

AMD AMD
$147.96 /

+2 (+1.37%)

JNJ Johnson & Johnson
$164.97 /

+1.9 (+1.17%)

11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
BKNG Booking Holdings
$2,453.11 /

-23.96 (-0.97%)

11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 Argus
Booking Holdings upgraded to Buy from Hold at Argus
11/10/21 Argus
Booking Holdings upgraded to Buy from Hold at Argus
11/08/21 Susquehanna
Booking Holdings price target raised to $3100 from $2850 at Susquehanna
WRBY Warby Parker
$58.38 /

+4.905 (+9.17%)

10/26/21 Citi
Warby Parker initiated with a Buy at Citi
10/25/21
Fly Intel: Top five analyst initiations
10/25/21 Cowen
Cowen starts 'disruptive' Warby Parker at Outperform
10/25/21 Evercore ISI
Warby Parker initiated with an In Line at Evercore ISI
RIDE Lordstown Motors
$5.67 /

-1.235 (-17.90%)

11/12/21 R.F. Lafferty
R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
11/12/21 R.F. Lafferty
Lordstown Motors upgraded to Hold from Sell at R.F. Lafferty
11/12/21
Fly Intel: Top five analyst downgrades
11/12/21 RBC Capital
Lordstown Motors price target lowered to $4 from $5 at RBC Capital
JAMF Jamf Holding
$32.49 /

-8.77 (-21.26%)

11/12/21 Piper Sandler
Jamf selloff on Apple product a buying opportunity, says Piper Sandler
11/12/21 Barclays
Jamf Holding shares to remain range-bound, says Barclays
11/10/21 Needham
Needham sees Apple Business Essentials functionality competitive with Jamf Now
10/19/21 Needham
Jamf Holding price target raised to $55 from $45 at Needham
NVDA Nvidia
$303.98 /

+0.14 (+0.05%)

11/12/21 Wedbush
Nvidia downgraded to Neutral on valuation at Wedbush
11/12/21 Wedbush
Nvidia downgraded to Neutral from Outperform at Wedbush
11/11/21 Craig-Hallum
Aeva Technologies price target lowered to $15 from $20 at Craig-Hallum
PENN Penn National
$58.32 /

+0.12 (+0.21%)

11/12/21
Fly Intel: Top five analyst upgrades
11/12/21 Deutsche Bank
Deutsche upgrades Penn National to Hold after stock underperformance
11/12/21 Deutsche Bank
Penn National upgraded to Hold from Sell at Deutsche Bank
11/05/21 Jefferies
Penn National price target lowered to $62 from $81 at Jefferies
CZR Caesars
$106.10 /

+4.155 (+4.08%)

11/12/21
Fly Intel: Top five analyst initiations
11/12/21 B. Riley
B. Riley starts 'mispriced empire' Caesars with Buy, $191 target
11/12/21 B. Riley
Caesars initiated with a Buy at B. Riley
11/03/21 Morgan Stanley
Caesars' sports betting share 'starting to impress,' says Morgan Stanley
HPE HP Enterprise
$14.66 /

-1.28 (-8.03%)

11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
09/03/21 Raymond James
HP Enterprise price target raised to $22 from $20 at Raymond James
09/03/21 Wells Fargo
HP Enterprise price target raised to $20 from $18 at Wells Fargo
LH LabCorp
$297.46 /

+10.57 (+3.68%)

10/19/21 Citi
Citi opens 'Positive Catalyst watches' on Quest, LabCorp
08/20/21 Credit Suisse
LabCorp price target raised to $336 from $295 at Credit Suisse
08/19/21 Mizuho
LabCorp price target raised to $332 from $318 at Mizuho
07/30/21 Truist
LabCorp price target raised to $350 from $330 at Truist
SYNH Syneos Health
$94.00 /

-8.59 (-8.37%)

11/04/21 Baird
Syneos Health price target raised to $122 from $115 at Baird
11/04/21 Barclays
Syneos Health upgraded to Overweight from Equal Weight at Barclays
08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
GE General Electric
$107.53 /

+0.555 (+0.52%)

11/10/21 Wells Fargo
General Electric price target raised to $120 from $110 at Wells Fargo
11/10/21 JPMorgan
JPMorgan's Tusa sees fair value for GE shares under $70
11/09/21 Deutsche Bank
General Electric upgraded to Buy at Deutsche Bank on updated sum-of-the-parts
11/09/21 Deutsche Bank
General Electric upgraded to Buy from Hold at Deutsche Bank
RIVN Rivian Automotive
$129.36 /

+6.52 (+5.31%)

CONE CyrusOne
$85.23 /

+2.51 (+3.03%)

10/29/21 Deutsche Bank
CyrusOne price target raised to $85 from $82 at Deutsche Bank
10/26/21 Evercore ISI
CyrusOne initiated with an Outperform at Evercore ISI
10/20/21 Cowen
Cowen upgrades CyrusOne to Outperform, sees takeover as 'imminent'
10/20/21 Cowen
CyrusOne upgraded to Outperform from Market Perform at Cowen
SRNE Sorrento Therapeutics
$6.42 /

+0.045 (+0.71%)

08/09/21 H.C. Wainwright
Sorrento Therapeutics price target lowered to $26 from $30 at H.C. Wainwright
03/26/21 B. Riley
Sorrento data make case for expedited EUA filing path, says B. Riley Securities
01/29/21 B. Riley
Sorrento Therapeutics initiated with a Buy at B. Riley Securities
01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
HYZN Hyzon Motors
$7.17 /

+0.875 (+13.90%)

10/19/21 Goldman Sachs
Hyzon Motors initiated with a Neutral at Goldman Sachs
09/09/21 JPMorgan
Hyzon Motors initiated with an Overweight at JPMorgan
08/31/21 Wedbush
Hyzon Motors price target raised to $15 from $10 at Wedbush
08/13/21 Wedbush
Wedbush starts hydrogen vehicle 'winner' Hyzon Motors at Outperform
NGD New Gold
$1.76 /

+0.145 (+9.01%)

09/14/21 Canaccord
New Gold price target lowered to C$2 from C$2.75 at Canaccord
09/14/21 BMO Capital
New Gold price target lowered to C$3.25 from C$3.50 at BMO Capital
09/14/21 National Bank
New Gold price target lowered to C$2 from C$2.50 at National Bank
09/14/21 Canaccord
New Gold price target lowered to C$2.00 from C$2.75 at Canaccord
PAGS PagSeguro Digital
$35.40 /

+1.38 (+4.06%)

11/12/21 Deutsche Bank
PagSeguro Digital price target lowered to $58 from $70 at Deutsche Bank
10/18/21 Deutsche Bank
PagSeguro concerns have no long-term impact, says Deutsche Bank
10/12/21 Goldman Sachs
PagSeguro recent selloff may be overdone, says Goldman Sachs
10/11/21 Citi
Brazil's proposed fee cap could remove 4% of PagSeguro revenue, says Citi
CGEN Compugen
$5.84 /

-1.32 (-18.44%)

HEPS Hepsiburada
$3.56 /

-2.06 (-36.65%)

08/31/21
Fly Intel: Top five analyst downgrades
08/31/21 BofA
Hepsiburada downgraded to Neutral from Buy at BofA
08/04/21
Fly Intel: Top five analyst initiations
08/04/21 HSBC
Hepsiburada initiated with a Buy at HSBC
FB Facebook; also tag MVRS
$340.00 /

+12.27 (+3.74%)

11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
11/08/21 Wells Fargo
AMD price target raised to $180 from $145 at Wells Fargo
CPNG Coupang
$26.60 /

-2.575 (-8.83%)

10/12/21 Citi
Coupang price target lowered to $32 from $39 at Citi
08/26/21 Daiwa
Coupang upgraded to Buy on improving fundamentals at Daiwa
08/26/21 Daiwa
Coupang upgraded to Buy from Outperform at Daiwa
08/12/21 Deutsche Bank
Coupang upgraded to Buy after earnings at Deutsche Bank
MAPS WM Technology
$9.50 /

-2.12 (-18.24%)

11/12/21 Truist
WM Technology price target lowered to $15 from $18 at Truist
11/12/21 Piper Sandler
WM Technology price target lowered to $14 from $16 at Piper Sandler
11/11/21 Benchmark
Merida Merger Corp. I initiated with a Buy at Benchmark
09/14/21 Piper Sandler
Piper says WM Technology improves software breadth with Sprout deal
AZN AstraZeneca
$58.87 /

-4.03 (-6.41%)

10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
BKKT Bakkt
$24.43 /

-1.75 (-6.68%)

11/11/21
Fly Intel: Top five analyst initiations
11/11/21 Jefferies
Jefferies starts Bakkt at Hold as more adoption 'proof-points' awaited
11/11/21 Jefferies
Bakkt initiated with a Hold at Jefferies
11/02/21 Piper Sandler
IntercontinentalExchange shares not reflecting positives, says Piper Sandler
BLNK Blink Charging
$39.98 /

+4.42 (+12.43%)

11/12/21 Roth Capital
Blink Charging upgraded to Buy from Neutral at Roth Capital
11/12/21 Roth Capital
Blink Charging upgraded to Buy from Neutral at Roth Capital
11/12/21 Cowen
Blink Charging price target raised to $41 from $35 at Cowen
SMAR Smartsheet
$72.69 /

+4.18 (+6.10%)

09/08/21 BMO Capital
Smartsheet price target raised to $90 from $78 at BMO Capital
09/08/21 Truist
Smartsheet price target raised to $100 from $85 at Truist
09/08/21 Needham
Smartsheet price target raised to $100 from $80 at Needham
09/08/21 KeyBanc
Smartsheet price target raised to $94 from $86 at KeyBanc
FLUX Flux Power
$6.14 /

+0.03 (+0.49%)

10/05/21 H.C. Wainwright
Flux Power initiated with a Buy at H.C. Wainwright
09/28/21 Maxim
Flux Power price target lowered to $13 from $15 at Maxim
05/12/21 Roth Capital
Flux Power price target lowered to $13 from $20 at Roth Capital
02/04/21
Fly Intel: Top five analyst initiations
SVRA Savara
$1.14 /

-0.02 (-1.72%)

09/10/21 Piper Sandler
Piper 'even more bullish' on Savara study after management meeting
06/30/21 Piper Sandler
Savara doses first patient in IMPALA-2 study, says Piper Sandler
05/24/21 Oppenheimer
Oppenheimer says Savara should not be overlooked, ups target to $5
04/19/21 Piper Sandler
Savara shares are trading below cash, says Piper Sandler
LAZR Luminar
$19.59 /

-0.4 (-2.00%)

11/12/21 R.F. Lafferty
Luminar price target lowered to $37 from $38 at R.F. Lafferty
06/25/21 Baird
Baird upgrades Luminar to Outperform ahead of expected outlook hike
06/25/21 Baird
Luminar upgraded to Outperform from Neutral at Baird
AMD AMD
$147.96 /

+2 (+1.37%)

11/09/21 Wedbush
AMD price target raised to $165 from $140 at Wedbush
XLNX Xilinx
$213.52 /

+4.69 (+2.25%)

10/28/21 Truist
Xilinx price target raised to $180 from $143 at Truist
10/28/21 Wells Fargo
Xilinx price target raised to $190 from $140 at Wells Fargo
10/28/21 Deutsche Bank
Xilinx price target raised to $195 from $155 at Deutsche Bank
10/28/21 Mizuho
Xilinx price target raised to $200 from $150 at Mizuho
XLNX Xilinx
$213.52 /

+4.69 (+2.25%)

WRBY Warby Parker
$58.38 /

+4.905 (+9.17%)

SYNH Syneos Health
$94.00 /

-8.59 (-8.37%)

SVRA Savara
$1.14 /

-0.02 (-1.72%)

SRNE Sorrento Therapeutics
$6.42 /

+0.045 (+0.71%)

SMAR Smartsheet
$72.69 /

+4.18 (+6.10%)

RIDE Lordstown Motors
$5.67 /

-1.235 (-17.90%)

PENN Penn National
$58.32 /

+0.12 (+0.21%)

PAGS PagSeguro Digital
$35.40 /

+1.38 (+4.06%)

NVDA Nvidia
$303.98 /

+0.14 (+0.05%)

NGD New Gold
$1.76 /

+0.145 (+9.01%)

MAPS WM Technology
$9.50 /

-2.12 (-18.24%)

LH LabCorp
$297.46 /

+10.57 (+3.68%)

LAZR Luminar
$19.59 /

-0.4 (-2.00%)

JNJ Johnson & Johnson
$164.97 /

+1.9 (+1.17%)

JAMF Jamf Holding
$32.49 /

-8.77 (-21.26%)

HYZN Hyzon Motors
$7.17 /

+0.875 (+13.90%)

HPE HP Enterprise
$14.66 /

-1.28 (-8.03%)

GE General Electric
$107.53 /

+0.555 (+0.52%)

FLUX Flux Power
$6.14 /

+0.03 (+0.49%)

FB Facebook; also tag MVRS
$340.00 /

+12.27 (+3.74%)

CZR Caesars
$106.10 /

+4.155 (+4.08%)

CPNG Coupang
$26.60 /

-2.575 (-8.83%)

CONE CyrusOne
$85.23 /

+2.51 (+3.03%)

CGEN Compugen
$5.84 /

-1.32 (-18.44%)

BLNK Blink Charging
$39.98 /

+4.42 (+12.43%)

BKNG Booking Holdings
$2,453.11 /

-23.96 (-0.97%)

BKKT Bakkt
$24.43 /

-1.75 (-6.68%)

AZN AstraZeneca
$58.87 /

-4.03 (-6.41%)

AMD AMD
$147.96 /

+2 (+1.37%)

  • 10
    Nov
  • 14
    Sep
  • 29
    Sep
  • 29
    Jun
  • 01
    Jul
  • 10
    Jun
  • 03
    Jun
  • 04
    May
  • 11
    Mar
  • 11
    Mar
  • 01
    Mar
  • 08
    Jan
  • 02
    Dec
  • 19
    Nov
RIVN Rivian Automotive
$129.36 /

+6.52 (+5.31%)

RIDE Lordstown Motors
$5.67 /

-1.235 (-17.90%)

PENN Penn National
$58.32 /

+0.12 (+0.21%)

PAGS PagSeguro Digital
$35.40 /

+1.38 (+4.06%)

NVDA Nvidia
$303.98 /

+0.14 (+0.05%)

LH LabCorp
$297.46 /

+10.57 (+3.68%)

LAZR Luminar
$19.59 /

-0.4 (-2.00%)

JNJ Johnson & Johnson
$164.97 /

+1.9 (+1.17%)

HPE HP Enterprise
$14.66 /

-1.28 (-8.03%)

GE General Electric
$107.53 /

+0.555 (+0.52%)

FB Facebook; also tag MVRS
$340.00 /

+12.27 (+3.74%)

CZR Caesars
$106.10 /

+4.155 (+4.08%)

CPNG Coupang
$26.60 /

-2.575 (-8.83%)

CONE CyrusOne
$85.23 /

+2.51 (+3.03%)

CGEN Compugen
$5.84 /

-1.32 (-18.44%)

BLNK Blink Charging
$39.98 /

+4.42 (+12.43%)

BKNG Booking Holdings
$2,453.11 /

-23.96 (-0.97%)

AZN AstraZeneca
$58.87 /

-4.03 (-6.41%)

AMD AMD
$147.96 /

+2 (+1.37%)

XLNX Xilinx
$213.52 /

+4.69 (+2.25%)

WRBY Warby Parker
$58.38 /

+4.905 (+9.17%)

SRNE Sorrento Therapeutics
$6.42 /

+0.045 (+0.71%)

SMAR Smartsheet
$72.69 /

+4.18 (+6.10%)

RIVN Rivian Automotive
$129.36 /

+6.52 (+5.31%)

RIDE Lordstown Motors
$5.67 /

-1.235 (-17.90%)

PENN Penn National
$58.32 /

+0.12 (+0.21%)

PAGS PagSeguro Digital
$35.40 /

+1.38 (+4.06%)

NVDA Nvidia
$303.98 /

+0.14 (+0.05%)

JNJ Johnson & Johnson
$164.97 /

+1.9 (+1.17%)

JAMF Jamf Holding
$32.49 /

-8.77 (-21.26%)

HYZN Hyzon Motors
$7.17 /

+0.875 (+13.90%)

HPE HP Enterprise
$14.66 /

-1.28 (-8.03%)

HEPS Hepsiburada
$3.56 /

-2.06 (-36.65%)

GE General Electric
$107.53 /

+0.555 (+0.52%)

FLUX Flux Power
$6.14 /

+0.03 (+0.49%)

FB Facebook; also tag MVRS
$340.00 /

+12.27 (+3.74%)

CZR Caesars
$106.10 /

+4.155 (+4.08%)

CPNG Coupang
$26.60 /

-2.575 (-8.83%)

CONE CyrusOne
$85.23 /

+2.51 (+3.03%)

BLNK Blink Charging
$39.98 /

+4.42 (+12.43%)

BKNG Booking Holdings
$2,453.11 /

-23.96 (-0.97%)

BKKT Bakkt
$24.43 /

-1.75 (-6.68%)

AZN AstraZeneca
$58.87 /

-4.03 (-6.41%)

XLNX Xilinx
$213.52 /

+4.69 (+2.25%)

WRBY Warby Parker
$58.38 /

+4.905 (+9.17%)

SRNE Sorrento Therapeutics
$6.42 /

+0.045 (+0.71%)

SMAR Smartsheet
$72.69 /

+4.18 (+6.10%)

RIDE Lordstown Motors
$5.67 /

-1.235 (-17.90%)

PENN Penn National
$58.32 /

+0.12 (+0.21%)

PAGS PagSeguro Digital
$35.40 /

+1.38 (+4.06%)

NVDA Nvidia
$303.98 /

+0.14 (+0.05%)

MAPS WM Technology
$9.50 /

-2.12 (-18.24%)

LAZR Luminar
$19.59 /

-0.4 (-2.00%)

JNJ Johnson & Johnson
$164.97 /

+1.9 (+1.17%)

HYZN Hyzon Motors
$7.17 /

+0.875 (+13.90%)

HPE HP Enterprise
$14.66 /

-1.28 (-8.03%)

GE General Electric
$107.53 /

+0.555 (+0.52%)

FB Facebook; also tag MVRS
$340.00 /

+12.27 (+3.74%)

CZR Caesars
$106.10 /

+4.155 (+4.08%)

CPNG Coupang
$26.60 /

-2.575 (-8.83%)

BLNK Blink Charging
$39.98 /

+4.42 (+12.43%)

BKNG Booking Holdings
$2,453.11 /

-23.96 (-0.97%)

BKKT Bakkt
$24.43 /

-1.75 (-6.68%)

AZN AstraZeneca
$58.87 /

-4.03 (-6.41%)

AMD AMD
$147.96 /

+2 (+1.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.